Advisory Committees
2010 Meeting Materials, Blood Products Advisory Committee
December 14-15, 2010: Meeting of the Blood Products Advisory Committee Meeting
On December 14, 2010, in the morning, the committee will discuss the risk of dengue virus infection in blood donors. In the afternoon, the committee will discuss murine leukemia virus-related human retroviruses and blood safety. On December 15, 2010, in the morning, the committee will hear updates on the following topics: (1) November 4 and 5, 2010, meeting of the Health and Human Services Advisory Committee on Blood Safety and Availability and...
- Agenda
- Announcement
- Announcement (Updated)
- Final Agenda
- Issue Summary
- Public Roster
- Presentations
- Reference Document
- Reference Documents for Topics I and II
- Roster
- Table of Studies (PDF - 68KB)
- Topic I: Risk of Dengue Virus Infection in Blood Donors (PDF - 356KB)
- Transcripts
- Waivers for Conflicts of Interest
July 26-27, 2010 Meeting of the Blood Products Advisory Committee
On July 26, in the morning session, the Committee will hear updates on the following topics: June 10-11, 2010 meeting of the HHS Advisory Committee on Blood Safety and Availability; December 14-15, 2009 FDA workshop on emerging arboviruses; May 11-12, 2010 FDA workshop on emerging infectious diseases; and the Q fever epidemic in the Netherlands.
- Announcement
- Waivers for Conflicts of Interest
- Draft Agenda (PDF - 22KB)
- Final Agenda (PDF - 22KB)
- Member Roster (PDF - 40KB)
- Administrative Personnel Roster
- Presentations
- Transcripts
- Topic 1- Final Babesia Issue Summary (PDF - 867KB)
Persons with disabilities having problems accessing any of these files may call 301-827-1277 for assistance. - Topic 2- Hemoglobin and Iron Issue Summary (PDF - 252KB)
Persons with disabilities having problems accessing any of these files may call 301-827-1277 for assistance. - Xenotropic Murine Leukemia Virus-Related Virus (XMRV) – Informational Presentation
April 12, 2010 Meeting of the Blood Products Advisory Committee
On April 12, 2010, the committee will meet in open session to hear updates on the research programs of the Laboratory of Cellular Hematology and the Laboratory of Biochemistry and Vascular Biology, Division of Hematology, Office of Blood Research and Review, CBER, FDA.
